Blocking of CDC25B suppresses sarcoma progression via arresting cell cycle
Related Experiment Video
Updated: Sep 14, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Renqin Lin1,2,3, Jianhua Lin1,2,3
1Department of Orthopedics, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Background:
Soft tissue sarcoma is a malignant tumor originating from mesenchymal tissue, accounting for approximately 1% of adult malignancies. Cell division cycle protein 25B (CDC25B) plays a crucial role in human diseases, however, its function in soft tissue sarcoma remains poorly understood. This study aims to explore the prognostic and therapeutic values of CDC25B in sarcoma.
Methods:
The expression and prognostic values of CDC25B in sarcoma were analyzed using bioinformatics approaches. Additionally, a CDC25B inhibitor (CDC25B-IN-1) was used to evaluate the potential therapeutic value of the CDC25B target using Cell Counting Kit-8 (CCK-8), quantitative polymerase chain reaction (qPCR) detection, 5-ethynyl-2'-deoxyuridine (EdU), colony formation, transwell, wound healing, flow cytometry and western blot (WB) assays.
Results:
The bioinformatics analysis found that CDC25B is overexpressed in sarcoma tissues, and high expression of CDC25B correlated with lower disease-specific survival (DSS), progress-free interval (PFI), and overall survival (OS). The univariate and multivariate analysis identified CDC25B as an independent prognostic biomarker in sarcoma. Experimental validation demonstrated that blocking CDC25B using CDC25B inhibitor (CDC25B-IN-1) can suppress sarcoma progression by inducing G2 cell cycle arrest.
Conclusions:
CDC25B is highly expressed in sarcoma, and blocking of CDC25B can suppress sarcoma progression by inducing G2 cell cycle arrest. These findings suggest that CDC25B may serve as a potential molecular biomarker and therapeutic target for sarcoma.
Insights
Cell division cycle protein 25B (CDC25B) is overexpressed in soft tissue sarcoma, correlating with poorer survival. Inhibiting CDC25B suppresses sarcoma progression by inducing cell cycle arrest, suggesting it as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Soft tissue sarcoma is a rare malignancy originating from mesenchymal tissue.
- The role of Cell Division Cycle Protein 25B (CDC25B) in sarcoma pathogenesis is not well understood.
- CDC25B is implicated in various human diseases, highlighting its potential relevance in cancer.
Purpose of the Study:
- To investigate the prognostic significance of CDC25B in sarcoma.
- To explore the therapeutic potential of targeting CDC25B in sarcoma.
- To elucidate the mechanism by which CDC25B influences sarcoma progression.
Main Methods:
- Bioinformatic analysis of CDC25B expression and its correlation with survival outcomes in sarcoma.
- In vitro experiments using a CDC25B inhibitor (CDC25B-IN-1) to assess its effects on sarcoma cells.
- Assays included CCK-8, qPCR, EdU, colony formation, transwell migration, wound healing, flow cytometry, and Western blot.
Main Results:
- CDC25B was found to be overexpressed in sarcoma tissues.
- High CDC25B expression was significantly associated with decreased disease-specific survival, progress-free interval, and overall survival.
- Inhibition of CDC25B suppressed sarcoma cell proliferation, migration, and induced G2 cell cycle arrest, confirming its role in progression.
Conclusions:
- CDC25B is an independent prognostic biomarker for sarcoma.
- Targeting CDC25B with inhibitors presents a promising therapeutic strategy for sarcoma.
- CDC25B's role in cell cycle regulation offers a mechanistic basis for its therapeutic targeting in sarcoma.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Negative Regulator Molecules
Anaphase Promoting Complex
DNA Damage can Stall the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

